Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04648631 · ClinicalTrials.gov registry record · NA
Hidradenitis Suppurativa (HS) Tunneling Wounds
A NA study of Hidradenitis Suppurativa, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04648631: Completed NA study of Hidradenitis Suppurativa, sponsored by University of Miami.
NCT04648631 is a NA study of Hidradenitis Suppurativa that has completed, run by University of Miami. The registered enrollment target is 15 participants, below the 598-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04648631, a NA study of Hidradenitis Suppurativa, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to look at the change in the microbiome (bacterial composition) of an HS tunneling wound and examine if treatment with an antibiofilm surfactant wound gel (ABWG) (a topical medication that will fight bacteria attached to the surface of those tunnels) changes the bacterial composition of the wounds.
Primary Outcome
As measured by quantitative 16s rDNA Polymerase Chain Reaction for bacterial enumeration from punch biopsy samples.
Conditions Studied
Interventions
- DEVICE antibiofilm surfactant wound gel (ABWG)
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-02-26 |
| Est. Completion | 2022-07-28 |
| Phase | NA |
What the finished NCT04648631 record still lists
NCT04648631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 598-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Hidradenitis Suppurativa appearing as the primary indexed condition, and to 1 intervention - of which antibiofilm surfactant wound gel (ABWG) is the first listed.
NCT04648631 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04648631 about?
NCT04648631 is a clinical study titled "Hidradenitis Suppurativa (HS) Tunneling Wounds". The purpose of this study is to look at the change in the microbiome (bacterial composition) of an HS tunneling wound and examine if treatment with an antibiofilm surfactant wound gel (ABWG) (a topical medication that will fight bacteria attached to the surface of those tunnels) changes the bacteria...
What is the current status of trial NCT04648631?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-02-26. Estimated completion is 2022-07-28.
What conditions does trial NCT04648631 study?
This clinical trial studies the following conditions: Hidradenitis Suppurativa.
What interventions are being tested in trial NCT04648631?
The interventions under investigation include: antibiofilm surfactant wound gel (ABWG) (DEVICE).
Who is sponsoring clinical trial NCT04648631?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04648631 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hidradenitis Suppurativa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04648631's enrollment target sits among peer trials
15 47th of 52 higher than 5 of 52 other Hidradenitis Suppurativa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hidradenitis Suppurativa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Aviclear for Hidradenitis Suppurativa (HS)
RECRUITING · NA
-
Physical Activity in Hidradenitis Suppurativa (HS)
RECRUITING · NA
-
Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
RECRUITING · NA
-
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
RECRUITING · NA
-
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
COMPLETED · NA
-
Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI